588 results
Management of type 2 diabetes in adults: summary of updated NICE guidance
#diabetes #type2 #DM2 #management #NICE
Management of type 2 diabetes ... NICE guidance #diabetes ... #type2 #DM2 #management ... #medications #insulin
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... pocketcardset #Diabetes ... #Mellitus #DM2
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Type 2 Diabetes ... -> Start Basal Insulin ... after starting insulin ... relative with DM2 ... Management #algorithm #DM2
The “twin cycles” of diabetes, first introduced by Roy Taylor in 2008.  
#fatty liver #fatty
twin cycles” of diabetes ... fatty pancreas #diabetes ... #t2d #dm2 #insulin
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... EricsMedicalLectures/featured #diabetes ... endocrinology #dm2
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
Dose (TDD) of Insulin ... TDD in units of insulin ... weight in Kg • Insulin ... endocrinology #diabetes ... #DM2
INSULIN CONVERSION

Total daily dose of insulin (TDD) =
INSULIN CONVERSION ... daily dose of insulin ... & most type 2 DM ... #diabetes #hyperglycemia ... #dm2 #basalinsulin
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... Glucophage) 2 INSULIN ... Hypoglycemics #Diabetes ... #pharmacology #DM2
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
cells, triggering insulin ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
• Increases insulin-mediated ... mL/minute/1.73 rm2 ... mL/minute/1.73 m2 ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology